Skip to content
The GLP-1 Verdict
Menu
Ranked #32 · Grade B

Henry Meds review

A flat-fee compounded pioneer — simple model, but priced at the higher end now.

Visit Henry Meds Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Brand-name
Compounded only

The scorecard

Henry Meds scored on our six published factors. See the methodology.

Real-world results85/100
Price honesty85/100
Prescriber access84/100
Formulary choice82/100
Cancellation fairness84/100
Member support84/100

What we like

  • Simple flat-fee model
  • Well-established brand
  • Both molecules

The caveats

  • Higher pricing than many newer entrants
  • Compounded only

The verdict

Best for: People who want a simple, well-known flat-fee compounded program. A flat-fee compounded pioneer — simple model, but priced at the higher end now.

Ranked #32 of 539 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. In the ranking it sits between Alan Meds at #31, 84/100 above and Live Vital at #33, 83/100 below, with the REMEVi ruling the next one down.

Weighing it against something else? Every provider we would put in front of Henry Meds is ranked on price honesty, prescriber access and cancellation terms.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs Henry Meds goes to CoreAge Rx, 94/100 to 84/100.

Compare with other providers

The closest rulings to Henry Meds by Verdict Score — the realistic shortlist if you are weighing this one up.

Browse all 539 rulings, ranked →

Pricing, states and verification reflect Henry Meds's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.

← Back to all rankings